Subscribe To
Incyte shares drop after fda approves gsk's competing blood-cancer treatment
Incyte Corp. INCY, -1.47% shares dropped more than 5% premarket on Monday after the U.S. Food and Drug Administration on Friday approved a GSK PLC GSK...
September 18, 2023, 8:11 am
Atai life sciences: rl-007, targeting schizophrenia subpopulation with no fda approved therapies
Atai Life Sciences is advancing RL-007 for the treatment of cognitive impairment associated with schizophrenia, with top-line results expected in the ...
September 1, 2023, 7:02 pm
Regeneron pharmaceuticals shares rise on fda approval of higher dose of eye disorder drug eylea
Regeneron Pharmaceuticals (NASDAQ:REGN) shares moved higher in pre-market trading after the biotechnology company reported on Friday that a higher dos...
August 21, 2023, 9:01 am
Regeneron gets boost with fda approval of high-dose eylea (rating upgrade)
Regeneron reported strong Q2 2023 financial results, with an 11% YoY revenue surge to $3.2B, outperforming expectations. The ...
August 19, 2023, 6:18 am
Why shares of sage therapeutics slumped this week
The fda approved Zurzuvae for postpartum depression but not for major depressive disorder. Sage saw rev...
August 11, 2023, 11:23 am
Sage therapeutics stock plunges 48% after fda decision on postpartum depression drug
The fda approved the pill Zuranolone, developed by Sage and Biogen, for postpartum depression but decli...
August 7, 2023, 10:52 am
The great market miscalculation: pfizer's true value remains untapped
Ngenla, a long-acting medicine for treating children with growth hormone deficiency, has been approved by the FDA for use in the United States, adding...
June 30, 2023, 9:15 am
: pfizer gets fda approval for rsv vaccine abrysvo in older adults
Pfizer Inc. PFE said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. T...
May 31, 2023, 10:53 pm
Pfizer gets fda approval for rsv vaccine abrysvo in older adults
Pfizer Inc. PFE said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. T...
May 31, 2023, 6:53 pm
Krystal clear: krystal biotech clears resistance in good volume
Last week, shares of the Pittsburgh-based genetic medicines developer surged more than 25% after the fda appro...
May 30, 2023, 7:36 am
Krystal biotech stock rises after fda approves treatment for rare skin disease
Krystal Biotech Inc. KRYS, +5.49% shares rose Friday after the biotech drug company received Food and Drug Administration approval of a rare skin dise...
May 19, 2023, 2:39 pm
Why emergent biosolutions stock is soaring today
The fda approved the use of Narcan as an over-the-counter treatment for opioid overdoses on Wednesday. ...
March 30, 2023, 11:56 am
The fda approved the alzheimer’s drug leqembi from eisai and biogen
The fda approved the Alzheimer’s drug Leqembi from Eisai and Biogen Read Full Story The post The
January 6, 2023, 7:25 pm
Empower clinics inks partnership deal to sell fda-approved atlas medical products in us
Empower Clinics Inc announced that it has signed a partnership agreement with Alp Medtech AG, the authorized representative of European medical device...
December 19, 2022, 10:54 am
United therapeutics: stock with strong growth and attractive valuation
United Therapeutics is profitable with 5 fda approved drugs on the market. The company has strong, doub...
November 25, 2022, 9:55 pm
Mannkind corporation: ready for your biotech portfolio
Once a highly speculative, non-revenue generating biotech on the verge of bankruptcy MNKD has de-risked much of the previous market concerns over bank...
September 1, 2022, 12:31 pm
Q biomed says new publication shows superior safety and efficacy of uttroside-b versus fda approved drug sorafenib
Q BioMed Inc has highlighted that its pre-clinical Uttroside-B chemotherapeutic to treat liver cancer has been found in a new study to show superior s...
July 26, 2022, 10:10 am
Pulmonx: interesting technology but struggling with adoption
fda approved technology to treat severe emphysema. Sizeable $12 billion market opportunity....
July 2, 2022, 3:04 am
Nevro: fda approved lower back pain relief without opiates or surgery
Nevro is the top pure play spinal cord stimulation [SCS] company with three major industry competitors. Nevro's recent FDA approvals for its high freq...
June 10, 2022, 2:00 am
Why eli lilly shares are trading higher today
The FDA approved Eli Lilly And Co's (NYSE: LLY) injected drug tirzepatide, which has the brand name Mounjaro (tirzepatide), to help improve blood s...
May 16, 2022, 10:04 am
